Spero Therapeutics, Inc. (SPRO) vs Verrica Pharmaceuticals Inc. (VRCA)
- Spero Therapeutics, Inc. SPRO 1.10 −2.65%
- Verrica Pharmaceuticals Inc. VRCA 3.54 −6.35%
Spero Therapeutics, Inc. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. Spero Therapeutics, Inc. and Verrica Pharmaceuticals Inc. are of similar size ($65.8M and $64.9M). Verrica Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Spero Therapeutics, Inc. trades at 7.9×. Verrica Pharmaceuticals Inc. grew revenue faster over the last twelve months: 106.2% against 37.2%. Spero Therapeutics, Inc. has the higher net margin (0.00% vs −102.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Spero Therapeutics, Inc. leads on 14 and Verrica Pharmaceuticals Inc. on 2.
Valuation
Profitability
| Metric | SPRO | VRCA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 85.89% | 65.16% |
| Operating margin | 0.00% | (93.59%) | 0.00% |
| Net margin | 0.00% | (102.84%) | 0.00% |
| Free cash flow margin | 0.00% | (44.02%) | 0.00% |
| Return on equity | 19.17% | 473.29% | (56.36%) |
| Return on assets | 12.85% | (83.02%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack